TOI Oncology Institute, Inc.

Nasdaq theoncologyinstitute.com


$ 4.06 $ -0.05 (-1.22 %)    

Thursday, 16-Oct-2025 10:41:23 EDT
QQQ $ 607.88 $ 2.64 (0.44 %)
DIA $ 463.87 $ 0.50 (0.11 %)
SPY $ 668.28 $ 1.39 (0.21 %)
TLT $ 90.51 $ 0.02 (0.02 %)
GLD $ 392.12 $ 1.04 (0.27 %)
$ 4.01
$ 4.11
$ 4.06 x 600
$ 4.07 x 424
$ 4.06 - $ 4.24
$ 0.13 - $ 4.50
2,190,139
na
374.95M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-25-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-11-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-28-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oncology-institute-affirms-fy2025-sales-guidance-of-460000m-480000m-vs-465100m-est

Oncology Institute (NASDAQ:TOI) affirms FY2025 sales outlook from $460.000 million-$480.000 million to $460.000 million-$480.00...

 the-oncology-institute-q2-eps-015-misses-013-estimate-sales-119802m-beat-114600m-estimate

The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate ...

 b-riley-securities-initiates-coverage-on-oncology-institute-with-buy-rating-announces-price-target-of-6

B. Riley Securities analyst Yuan Zhi initiates coverage on Oncology Institute (NASDAQ:TOI) with a Buy rating and announces P...

 the-oncology-institute-named-exclusive-oncology-provider-for-80k-silversummit-medicaid-patients-in-nevada-starting-july-1-2025

The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI"), one of the largest value-based oncology groups in the United States,...

 the-oncology-institute-files-for-stock-shelf-of-up-to-50m

-SEC Filing

 oncology-institute-affirms-fy2025-sales-guidance-of-46000m-48000m-vs-48280m-est

Oncology Institute (NASDAQ:TOI) affirms FY2025 sales outlook from $460.00 million-$480.00 million to $460.00 million-$480.00 mi...

 the-oncology-institute-q1-gaap-eps-021-up-from-022-yoy-sales-10441m-up-from-9467m-yoy

The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.21) per share. This is a 4.55 percent increase over losses...

 the-oncology-institute-files-prospectus-for-the-resale-of-up-to-2792m-shares-of-common-stock-by-selling-securityholders

The Oncology Institute, Inc.27,924,611 SharesCommon StockOffered by the Selling Securityholders This prospectus relates to the ...

 the-oncology-institute-announces-enterprise-wide-expansion-of-strategic-partnership-with-helios-clinical-research

CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Compa...

 the-oncology-institute-expects-fy2025-revenue-of-460m-480m-vs-consensus-of-48280m

 2025 Guidance Revenue$460 to $480 million Gross Profit$73 to $82 million Adjusted EBITDA$(8) to $(17) million Free Cash Flow$(...

 the-oncology-institute-entered-into-a-securities-purchase-agreement-with-accredited-investors-for-a-private-placement-in-gross-proceeds-of-approximately-165m

Pursuant to the terms of the Securities Purchase Agreement, the Company will issue to purchasers in the Private Placement units...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION